Our product is a non-invasive fetal pulse oximeter. It provides critical information about the birthing fetus to the clinician. We have booked our first sales. We have completed a 10 patient safety trial in Belgium. We are conducting trials in Qatar (N=150), Spain (N=75), and Abu Dhabi (N=50). We have an established manufacturing line in France with established vendors and suppliers.